Eisai
4523.T
#2199
Rank
NZ$14.49 B
Marketcap
NZ$51.40
Share price
-2.38%
Change (1 day)
4.21%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2023: NZ$0.89 Billion

According to Eisai's latest financial reports the company's current earnings are NZ$5.06 Billion. In 2023 the company made an earning of NZ$0.89 Billion, an increase over its 2022 earnings that were of -NZ$38.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2023

Annual earnings

Year Earnings Change
2023NZ$0.89 B-2404.04%
2022-NZ$38.89 Million-103.6%
2021NZ$1.08 B-39.81%
2020NZ$1.79 B7.44%
2019NZ$1.67 B17.22%
2018NZ$1.42 B86.16%
2017NZ$0.76 B-23.52%
2016NZ$1.00 B26.97%
2015NZ$0.78 B22.3%
2014NZ$0.64 B-46.07%
2013NZ$1.19 B-21.85%
2012NZ$1.53 B-20.59%
2011NZ$1.92 B-8.91%
2010NZ$2.11 B19.21%
2009NZ$1.77 B